Why Use G CSF or Plerixafor?
In some workflows, especially those involving CD34 positive stem cells, standard leukapheresis does not provide sufficient yield. This is where donor mobilization becomes important.
Mobilizing agents such as G CSF or plerixafor stimulate the movement of hematopoietic stem and progenitor cells from the bone marrow into peripheral blood. The result is a significant increase in circulating CD34 positive cells.
Mobilized collections are commonly used for:
🩸 gene therapy starting material
🩸 stem cell engineering
🩸 ex vivo expansion workflows
🩸 transplantation research
🩸 large scale cell therapy development
By increasing available stem cell yield, mobilized donors enable manufacturing processes that would otherwise be difficult or inefficient.
Selecting between mobilized and non mobilized donors depends on the required cell type, target yield, and downstream application.
From Cell to Impact
Where Immune Biology Becomes Therapy and Data
